Emerald Health Sciences Inc.
CIK 1728413 · View on SEC EDGAR ↗
Insider
First SEC filing: Jan. 29, 2018 · Latest: Jan. 31, 2022
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 11 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
11 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 16, 2018 | SKYE | P | 20,400,000 | — | — | 20,400,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 16, 2018 | SKYE | P | 15,000,000 | — | — | 39,000,000 Direct | +62.50% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 1, 2019 | SKYE | Warrant (Right to Buy) | Common Stock (2,500,000) | $0.50 | — | 2,500,000 | Acquired |
| Feb. 1, 2019 | SKYE | 7% Convertible Debt | Common Stock (5,000,000) | $0.40 | — | — | Acquired |
| Nov. 1, 2018 | SKYE | Warrant (Right to Buy) | Common Stock (2,500,000) | $0.50 | — | 2,500,000 | Acquired |
| Nov. 1, 2018 | SKYE | 7% Convertible Debt | Common Stock (5,000,000) | $0.40 | — | — | Acquired |
| March 29, 2018 | SKYE | Series F Convertible Preferred Stock | Common Stock (20,000,000) | $0.10 | — | 2,000 | Disposed |
| March 29, 2018 | SKYE | Series B Convertible Preferred Stock | Common Stock (12,335,000) | $0.10 | — | 1,234 | Disposed |
| Feb. 16, 2018 | SKYE | Common Stock Warrants (right to buy) | Common Stock (20,400,000) | $0.10 | Feb. 16, 2023 | 20,400,000 | Acquired |
| Jan. 24, 2018 | SKYE | Common Stock Warrant (Right to Buy) | Common Stock (1,781,250) | $0.00 | Aug. 20, 2020 | 1,781,250 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 29, 2018 | SKYE | Common Stock | 24,000,000 | Direct |
| Jan. 29, 2018 | SKYE | Series B Convertible Preferred Stock→ Common Stock (12,335,000) | 12,335,000 | Direct |
| Jan. 29, 2018 | SKYE | Series F Convertible Preferred Stock→ Common Stock (20,000,000) | 20,000,000 | Direct |
| Jan. 29, 2018 | SKYE | Common Stock Warrants (right to buy)→ Common Stock (20,400,000) | 20,400,000 | Direct |